STOPBANG versus NOSAS in screening patients with severe obstructive sleep apnea

##plugins.themes.academic_pro.article.sidebar##

Published Feb 15, 2026
https://doi.org/10.62438/tunismed.v103i12.6066
Download
PDF
Vol. 103 No. 12 (2025): Tunis Med Dec 2025

##plugins.themes.academic_pro.article.main##

Emna Ben Jemia
Service of Pneumology, Charles Nicolles Hospital , Faculty of Medicine of Tunis, University of El Manar,1001,Tunis, Tunisia
Sara Trimech
Service of Pneumology, Charles Nicolles Hospital, Faculty of Medicine of Tunis, University of El Manar,1001,Tunis, Tunisia
Hend Ouertani
Service of Pneumology, Charles Nicolles Hospital, Faculty of Medicine of Tunis, University of El Manar,1001,Tunis, Tunisia
Salsabil Rejaibi
Department of Preventive and Community Medicine , Faculty of Medicine of Tunis, University of El Manar, Tunis, Tunisia
Hana Hedhli
Department of Emergency, Hospital of Charles Nicolles, Faculty of Medicine of Tunis, University of El Manar, 1001,Tunis, Tunisia
Jihen Ben Amar
Service of Pneumology, Charles Nicolles Hospital, Faculty of Medicine of Tunis, University of El Manar,1001,Tunis, Tunisia
Haifa Zaibi
Service of Pneumology, Charles Nicolles Hospital, Faculty of Medicine of Tunis, University of El Manar,1001,Tunis, Tunisia

Abstract

Introduction: Obstructive sleep apnea (OSA) is a prevalent sleep disorder characterized by repeated upper airway obstruction during sleep. It can lead to significant health risks, and early detection is essential for effective management.
Aim: To evaluate the diagnostic performance of STOP-BANG and NoSAS questionnaires in identifying severe OSA.
Method: Patients with confirmed sleep disorders by ventilator polygraphy were enrolled in this cross-sectional study conducted over 18 months in the Pneumonology department of Charles Nicolle Hospital of Tunis. All participants completed STOP-BANG and NoSAS questionnaires.
Results: A total of 172 patients diagnosed with OSA were enrolled, with a mean age of 54.4 years. OSA severity was classified as mild in 63 patients (36.6%), moderate in 45 patients (26.2%), and severe (apnea-hypopnea index ≥30/h) in 64 patients (37.2%). Severe OSA was significantly associated with male (p=0.04), older age (p=0.019), higher BMI (p<0.001), larger neck circumference (p<0.001), and greater fatigue (p=0.037). STOP-Bang and NoSAS scores demonstrated high discriminative value, with areas under the curve (AUC) of 0.61 and 0.64, respectively. STOP-BANG score showed higher sensitivity (65.2%) compared to NoSAS (34.8%), while NoSAS exhibited superior specificity (85.6% vs 53.8%). Positive predictive values were comparable between scores, but NoSAS had a slightly higher negative predictive value (82.9% vs 81.5%).
Conclusion: These findings suggest that while STOP-BANG is more sensitive for identifying severe OSA, NoSAS offers better specificity, making it a valuable tool for screening in specific populations. Combining both scores may enhance diagnostic accuracy and improve early detection of severe OSA, thereby optimizing patient outcomes.

Keywords:

Sleep apnea, screening, score, severity, STOPBANG questionnaire, NoSAS score

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Author Biography

Sara Trimech, Service of Pneumology, Charles Nicolles Hospital, Faculty of Medicine of Tunis, University of El Manar,1001,Tunis, Tunisia

3rd year resident in pneumology

References

  1. Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K, et al. Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017 Mar 15;13(03):479–504.
  2. Ng SSS, Tam WWS, Lee RWW, Chan TO, Yiu K, Yuen BTY, et al. Effect of Weight Loss and Continuous Positive Airway Pressure on Obstructive Sleep Apnea and Metabolic Profile Stratified by Craniofacial Phenotype: A Randomized Clinical Trial. Am J Respir Crit Care Med. 2022 Mar 15;205(6):711–20.
  3. Grunstein RR, Stenlöf K, Hedner JA, Peltonen M, Karason K, Sjöström L. Two Year Reduction In Sleep Apnea Symptoms and Associated Diabetes Incidence After Weight Loss In Severe Obesity. Sleep. 2007 Jun;30(6):703–10.
  4. Lee KI, Choi JH. Positional Therapy for Obstructive Sleep Apnea: Therapeutic Modalities and Clinical Effects. Sleep Med Res. 2023 Sep 30;14(3):129–34.
  5. Qiao M, Xie Y, Wolff A, Kwon J. Long term adherence to continuous positive Airway pressure in mild obstructive sleep apnea. BMC Pulm Med. 2023 Sep 1;23(1):320.
  6. Ramar K, Dort LC, Katz SG, Lettieri CJ, Harrod CG, Thomas SM, et al. Clinical Practice Guideline for the Treatment of Obstructive Sleep Apnea and Snoring with Oral Appliance Therapy: An Update for 2015. J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med. 2015 Jul 15;11(7):773–827.
  7. Elshaug AG, Moss JR, Southcott AM, Hiller JE. Redefining success in airway surgery for obstructive sleep apnea: a meta analysis and synthesis of the evidence. Sleep. 2007 Apr;30(4):461–7.
  8. Chung F, Yegneswaran B, Liao P, Chung SA, Vairavanathan S, Islam S, et al. STOP Questionnaire. Anesthesiology. 2008 May 1;108(5):812–21.
  9. Marti-Soler H, Hirotsu C, Marques-Vidal P, Vollenweider P, Waeber G, Preisig M, et al. The NoSAS score for screening of sleep-disordered breathing: a derivation and validation study. Lancet Respir Med. 2016 Sep;4(9):742–8.
  10. Chung F, Abdullah HR, Liao P. STOP-Bang Questionnaire. Chest. 2016 Mar;149(3):631–8.
  11. Pivetta B, Chen L, Nagappa M, Saripella A, Waseem R, Englesakis M, et al. Use and Performance of the STOP-Bang Questionnaire for Obstructive Sleep Apnea Screening Across Geographic Regions: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2021 Mar 1;4(3):e211009.
  12. Georgakopoulou VE, Pantazis N, Tsiafaki X, Nena E, Amfilochiou A, Steiropoulos P. Validation of NoSAS score for the screening of obstructive sleep apnea. Med Int. 2023;3(2):14.
  13. Peng M, Chen R, Cheng J, Li J, Liu W, Hong C. Application value of the NoSAS score for screening sleep-disordered breathing. J Thorac Dis. 2018 Aug;10(8):4774–81.
  14. Johns MW. Reliability and Factor Analysis of the Epworth Sleepiness Scale. Sleep. 1992 Jul;15(4):376–81.
  15. Johns MW. A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale. Sleep. 1991 Nov 1;14(6):540–5.
  16. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med. 1999 Oct 5;131(7):485–91.